Celgene Corp (NASDAQ:CELG)

CAPS Rating: 4 out of 5

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

Recs

0
Player Avatar portefeuille (99.75) Submitted: 1/12/2012 8:34:07 PM : Outperform Start Price: $40.01 CELG Score: +19.90

There are currently 150 shares in my "fund" with break-even of around 58.02 USD.
http://caps.fool.com/Blogs/fund-trades/687712.
http://twitter.com/portefeuillefun.

Featured Broker Partners


Advertisement